Akademska digitalna zbirka SLovenije - logo
E-viri
Celotno besedilo
Recenzirano
  • Low Cost Gastroschisis Silo...
    Leraas, Harold J.; Biswas, Arushi; Eze, Anthony; Zadey, Siddesh; Wilson, Patrick; Theriot, Barbara S.; Surana, Neeraj K.; Ssekitoleko, Robert; Mugaga, Julius; Salzman, Caroline; Hall, Allison; Wesonga, Anne; Saterbak, Ann; Fitzgerald, Tamara N.

    World journal of surgery, February 2023, Letnik: 47, Številka: 2
    Journal Article

    Background Gastroschisis mortality in sub-Saharan Africa (SSA) remains high at 59–100%. Silo inaccessibility contributes to this disparity. Standard of care (SOC) silos cost $240, while median monthly incomes in SSA are < $200. Our multidisciplinary American and Ugandan team designed and bench-tested a low-cost (LC) silo that costs < $2 and is constructed from locally available materials. Here we describe in vivo LC silo testing. Methods A piglet gastroschisis model was achieved by eviscerating intestines through a midline incision. Eight piglets were randomized to LC or SOC silos. Bowel was placed into the LC or SOC silo, maintained for 1-h, and reduced. Procedure times for placement, intestinal reduction, and silo removal were recorded. Tissue injury of the abdominal wall and intestine was assessed. Bacterial and fungal growth on silos was also compared. Results There were no gross injuries to abdominal wall or intestine in either group or difference in minor bleeding. Times for silo application, bowel reduction, and silo removal between groups were not statistically or clinically different, indicating similar ease of use. Microbiologic analysis revealed growth on all samples, but density was below the standard peritoneal inoculum of 10 5  CFU/g for both silos. There was no significant difference in bacterial or fungal growth between LC and SOC silos. Conclusion LC silos designed for manufacturing and clinical use in SSA demonstrated similar ease of use, absence of tissue injury, and acceptable microbiology profile, similar to SOC silos. The findings will allow our team to proceed with a pilot study in Uganda.